Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma

被引:77
作者
Diniz-Freitas, M
García-Caballero, T
Antúnez-López, J
Gándara-Rey, JM
García-García, A
机构
[1] Univ Santiago de Compostela, Fac Med & Odontol, Sch Dent, Dept Oral Surg, Santiago De Compostela 15782, Spain
[2] Univ Santiago de Compostela, Dept Oral Med, Sch Dent, Santiago De Compostela 15782, Spain
[3] Univ Santiago de Compostela, Clin Univ Hosp, Sch Med & Dent, Dept Morphol Sci, Santiago De Compostela 15782, Spain
[4] Univ Santiago de Compostela, Clin Univ Hosp, Dept Pathol, Santiago De Compostela 15782, Spain
[5] Univ Santiago de Compostela, Clin Univ Hosp, Dept Oral Med, Santiago De Compostela 15782, Spain
[6] Univ Santiago de Compostela, Clin Univ Hosp, Dept Maxillofacial Surg, Santiago De Compostela 15782, Spain
关键词
squamous cell carcinoma; intercellular adhesion; E-cadherin;
D O I
10.1016/j.oraloncology.2005.07.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The aim was to evaluate E-cadherin expression in oral squamous cell carcinoma, and its possible relationships with tumour histology and with clinical course and survival. Surgical biopsies from 47 cases of oral squamous cell carcinoma were analysed for expression of E-cadherin using immunohistochemistry. Statistical analyses were performed to identify possible associations with tumour clinic-histological features and with clinical course and survival. Weak or absent E-cadherin expression was associated with a more invasive histological pattern and with metastasis to the cervical lymph nodes. Uni- and multivariate analyses indicated that weak or undetectable E-cadherin expression is an indicator of shorter disease-free period and shorter survival time. Reduced E-cadherin expression in oral squamous cell carcinoma is associated with more aggressive tumour behaviour and worse prognosis. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:190 / 200
页数:11
相关论文
共 31 条
[1]
Bagutti C, 1998, J PATHOL, V186, P8, DOI 10.1002/(SICI)1096-9896(199809)186:1<8::AID-PATH156>3.0.CO
[2]
2-H
[3]
Gains and losses of adhesion molecules (CD44, E-cadherin, and β-catenin) during oral carcinogenesis and tumour progression [J].
Bánkfalvi, A ;
Krassort, M ;
Buchwalow, IB ;
Végh, A ;
Felszeghy, E ;
Piffkó, J .
JOURNAL OF PATHOLOGY, 2002, 198 (03) :343-351
[4]
Deranged expression of the E-cadherin/β-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas [J].
Bánkfalvi, A ;
Krassort, M ;
Végh, A ;
Felszeghy, E ;
Piffkó, J .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2002, 31 (08) :450-457
[5]
BIRCHMEIER W, 1993, SEMIN CANCER BIOL, V4, P231
[6]
BOWIE GL, 1993, CLIN OTOLARYNGOL, V18, P196
[7]
Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance [J].
Chang, HW ;
Chow, V ;
Lam, KY ;
Wei, WI ;
Yuen, APW .
CANCER, 2002, 94 (02) :386-392
[8]
A comparative study of the clinicopathological significance of E-cadherin and catenins (α,β,γ) expression in the surgical management of oral tongue carcinoma [J].
Chow, V ;
Yuen, APW ;
Lam, KY ;
Tsao, GSW ;
Ho, WK ;
Wei, WI .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (01) :59-63
[9]
DOWNER CS, 1993, ORAL ONCOL, V29, P3003
[10]
Importance of tumour thickness measurement in prognosis of tongue cancer [J].
Gonzalez-Moles, MA ;
Esteban, F ;
Rodriguez-Archilla, A ;
Ruiz-Avila, I ;
Gonzalez-Moles, S .
ORAL ONCOLOGY, 2002, 38 (04) :394-397